1Kondo S, Yoneta A, Yazawa H, et al. Downregulation of CXCR- 2 but not CXCR- 1 expression by human keratinocytes by UVB. J Cell Physiol, 2000,182:366- 370.
2Vandenbark AA, Morgan E, Bartholomew R, et al. TCR peptide therapy in human autoimmune diseases. Neurochem Res, 2001,26:713- 730.
4Schroder JM, Harder J. Human beta- defensin- 2. Int J Biochem Cell Biol, 1999,31:645- 651.
5Nickoloff BJ. Creation of psoriatic plaques: the ultimate tumor suppressor pathway. A new model for an ancient T- cell- mediated skin disease. Viewpoint. J Cutan Pathol, 2001,28:57- 64.
6Hwang ST. Mechanisms of T cell homing to skin. Adv Dermatol, 2001,17:211- 241.
7Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol, 2002,46:1- 23.
8Aruffo A, Hollenbaugh D. Therapeutic intervention with inhibitors of co- stimulatory pathways in autoimmune disease. Curr Opin Immunol, 2001,13:683- 686.
9Molin L et al. Dermatology . 1999
10Oazwa A et al. European Journal of Dermatology . 1999
